Showing 701 - 720 results of 101,399 for search '(( 5 ((nm decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (mean decrease)) ))', query time: 1.76s Refine Results
  1. 701
  2. 702
  3. 703
  4. 704
  5. 705
  6. 706
  7. 707

    Decreased diaphragm muscle axonal branching distance, bifurcations and neuromuscular junctions in GAD67-deficient (−/−) E18.5 mice. by Matthew J. Fogarty (283288)

    Published 2013
    “…D shows a significantly decreased medial and lateral bifurcation number (mean ± SEM) in GAD67-deficient mice compared to wild type (<i>n</i> = 10, **<i>P</i><0.01, ***<i>P</i><0.001, unpaired <i>t</i> test). …”
  8. 708
  9. 709
  10. 710
  11. 711

    Data_Sheet_1_Microclimatic Warming Leads to a Decrease in Species and Growth Form Diversity: Insights From a Tropical Alpine Grassland.PDF by Sisimac A. Duchicela (11503918)

    Published 2021
    “…We installed five monitoring blocks in 2012 at ca. 4,200 m asl with 20 OTCs and 50 control plots randomly distributed within each block. …”
  12. 712
  13. 713
  14. 714
  15. 715
  16. 716

    Calcineurin acts as a Ca<sup>2+</sup> sensor for metamodulation of LP I<sub>h</sub> in 5nM DA. by Wulf-Dieter C. Krenz (693267)

    Published 2015
    “…Experiments were performed as described for <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0117965#pone.0117965.g005" target="_blank">Fig. 5</a> using the calcineurin inhibitor, FK506. …”
  17. 717
  18. 718
  19. 719

    PDGF-BB maintains Bcl2/Bax ratio and decreases caspase-3 activation induced by Tat and morphine. by Shaily Malik (226661)

    Published 2011
    “…<p>(A) Human neurons were treated with 100 ng/ml Tat and/or 100 nM morphine for 12 hours with or without pre-treatment with 40 ng/ml PDGF-BB. …”
  20. 720

    Image5_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”